Literature DB >> 19497326

Neospora caninum--how close are we to development of an efficacious vaccine that prevents abortion in cattle?

Michael P Reichel1, John T Ellis.   

Abstract

Neospora caninum is a protozoan parasite that causes abortion in cattle around the world. Although the clinical signs of disease in both dogs and cattle have now been recognised for over 20years, treatment and control options are still limited, despite the availability of a commercial vaccine in some countries of the world. The case for an efficacious vaccine has not been convincingly waged by farmers, veterinarians and other members of the agricultural and rural communities. In recent times, however, economic modelling has been used to estimate the industry losses due to Neospora-associated abortion, providing, in turn, the business case for forms of control for this parasite, including the development of vaccines. In this review, we document progress in all areas of the vaccine development pipeline, including live, killed and recombinant forms and the animal models available for vaccine evaluation. In addition, we summarise the main outcomes on the economics of Neospora control and suggest that the current boom in the global dairy industry increases the specific need for a vaccine against N. caninum-associated abortion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497326     DOI: 10.1016/j.ijpara.2009.05.007

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  27 in total

1.  Protective effect of intranasal immunization with Neospora caninum membrane antigens against murine neosporosis established through the gastrointestinal tract.

Authors:  Pedro Ferreirinha; Joana Dias; Alexandra Correia; Begoña Pérez-Cabezas; Carlos Santos; Luzia Teixeira; Adília Ribeiro; António Rocha; Manuel Vilanova
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

2.  Protection against lethal Neospora caninum infection in mice induced by heterologous vaccination with a mic1 mic3 knockout Toxoplasma gondii strain.

Authors:  Diana Marcela Penarete-Vargas; Marie Noelle Mévélec; Sarah Dion; Edouard Sèche; Isabelle Dimier-Poisson; Thierry Fandeur
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

3.  Standardization of the outbred BALB/c mice as a suitable animal model for Besnoitia caprae studies.

Authors:  Fatemeh Namazi; Mohamad Mehdi Namavari; Ebrahim Rahimi; Mohsen Lotfi; Yahya Tahamtan
Journal:  Vet Res Commun       Date:  2011-07-09       Impact factor: 2.459

4.  Tissue distribution of Neospora caninum in experimentally infected cattle.

Authors:  Maki Nishimura; Junko Kohara; Jun Hiasa; Yoshikage Muroi; Naoaki Yokoyama; Katsuya Kida; Xuenan Xuan; Hidefumi Furuoka; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

Review 5.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection.

Authors:  Masaki Uchida; Kotomi Nagashima; Yui Akatsuka; Takashi Murakami; Akira Ito; Soichi Imai; Kazunori Ike
Journal:  Parasitol Res       Date:  2012-11-15       Impact factor: 2.289

7.  CXCR3-Dependent Immune Pathology in Mice following Infection with Toxoplasma gondii during Early Pregnancy.

Authors:  Akari Nishida; Rina Ikeda; Hidefumi Furuoka; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

8.  On the efficacy and safety of vaccination with live tachyzoites of Neospora caninum for prevention of neospora-associated fetal loss in cattle.

Authors:  Fred H Weber; James A Jackson; Brian Sobecki; Les Choromanski; Mary Olsen; Todd Meinert; Rodney Frank; Michael P Reichel; John T Ellis
Journal:  Clin Vaccine Immunol       Date:  2012-11-21

9.  Bombyx mori nucleopolyhedrovirus displaying neospora caninum antigens as a vaccine candidate against N. caninum infection in mice.

Authors:  Tatsuya Kato; Takahiro Otsuki; Mai Yoshimoto; Kohei Itagaki; Tetsuya Kohsaka; Yumino Matsumoto; Kazunori Ike; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

10.  The core mouse response to infection by neospora caninum defined by gene set enrichment analyses.

Authors:  John Ellis; Stephen Goodswen; Paul J Kennedy; Stephen Bush
Journal:  Bioinform Biol Insights       Date:  2012-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.